Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 480

1.

Fettemboli er en utdatert diagnose.

Dahl OE, Reikerås O, Pripp AH, Engesæter LB.

Tidsskr Nor Laegeforen. 2018 Feb 19;138(4). doi: 10.4045/tidsskr.17.0946. Print 2018 Feb 20. Norwegian. No abstract available.

PMID:
29460584
Free Article
2.

Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.

Haugnes HS, Stenklev NC, Brydøy M, Dahl O, Wilsgaard T, Laukli E, Fosså SD.

Acta Oncol. 2018 Jan 31:1-9. doi: 10.1080/0284186X.2018.1433323. [Epub ahead of print]

PMID:
29384420
3.

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease.

Gaare JJ, Nido GS, Sztromwasser P, Knappskog PM, Dahl O, Lund-Johansen M, Alves G, Tysnes OB, Johansson S, Haugarvoll K, Tzoulis C.

Brain. 2018 Jan 24. doi: 10.1093/brain/awx378. [Epub ahead of print] No abstract available.

PMID:
29373637
4.

Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.

Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP.

Oncotarget. 2017 Sep 23;8(50):87837-87847. doi: 10.18632/oncotarget.21237. eCollection 2017 Oct 20.

5.

Risk of carotid blowout after reirradiation with particle therapy.

Dale JE, Molinelli S, Ciurlia E, Ciocca M, Bonora M, Vitolo V, Mirandola A, Russo S, Orecchia R, Dahl O, Fossati P.

Adv Radiat Oncol. 2017 Jul 6;2(3):465-474. doi: 10.1016/j.adro.2017.05.007. eCollection 2017 Jul-Sep.

6.

Similar Clinical Outcomes with Preoperative and Postoperative Start of Thromboprophylaxis in THA: A Register-based Study.

Borgen PO, Pripp AH, Dybvik E, Leistad L, Dahl OE, Reikerås O.

Clin Orthop Relat Res. 2017 Sep;475(9):2245-2252. doi: 10.1007/s11999-017-5419-1. Epub 2017 Jun 22.

PMID:
28643079
7.

Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.

Fjæra LF, Li Z, Ytre-Hauge KS, Muren LP, Indelicato DJ, Lassen-Ramshad Y, Engeseth GM, Brydøy M, Mairani A, Flampouri S, Dahl O, Stokkevåg CH.

Acta Oncol. 2017 Jun;56(6):763-768. doi: 10.1080/0284186X.2017.1314007. Epub 2017 Apr 19.

PMID:
28423966
8.

New alternative energy pathway for chemical pulp mills: From traditional fibers to methane production.

Rodriguez-Chiang L, Vanhatalo K, Llorca J, Dahl O.

Bioresour Technol. 2017 Jul;235:265-273. doi: 10.1016/j.biortech.2017.03.140. Epub 2017 Mar 25.

PMID:
28371764
9.

Thrombin Generation in Patients With Suspected Venous Thromboembolism.

Wexels F, Dahl OE, Pripp AH, Seljeflot I.

Clin Appl Thromb Hemost. 2017 Jul;23(5):416-421. doi: 10.1177/1076029617700999. Epub 2017 Mar 24.

PMID:
28335612
10.

Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O, Tronstad KJ.

JCI Insight. 2016 Dec 22;1(21):e89376. doi: 10.1172/jci.insight.89376.

11.

Safety compliance and safety climate: A repeated cross-sectional study in the oil and gas industry.

Kvalheim SA, Dahl Ø.

J Safety Res. 2016 Dec;59:33-41. doi: 10.1016/j.jsr.2016.10.006. Epub 2016 Oct 17.

PMID:
27846997
12.

Multimodal therapy is feasible in elderly anal cancer patients.

Dale JE, Sebjørnsen S, Leh S, Rösler C, Aaserud S, Møller B, Fluge Ø, Erichsen C, Nadipour S, Kørner H, Pfeffer F, Dahl O.

Acta Oncol. 2017 Jan;56(1):81-87. doi: 10.1080/0284186X.2016.1244356. Epub 2016 Nov 3.

PMID:
27808666
13.

Early assessment and identification of posttraumatic stress disorder, satisfaction with appearance and coping in patients with burns.

Dahl O, Wickman M, Björnhagen V, Friberg M, Wengström Y.

Burns. 2016 Dec;42(8):1678-1685. doi: 10.1016/j.burns.2016.09.012. Epub 2016 Oct 1.

PMID:
27707641
14.

Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone.

Cancedda C, Davis SM, Dierberg KL, Lascher J, Kelly JD, Barrie MB, Koroma AP, George P, Kamara AA, Marsh R, Sumbuya MS, Nutt CT, Scott KW, Thomas E, Bollbach K, Sesay A, Barrie A, Barrera E, Barron K, Welch J, Bhadelia N, Frankfurter RG, Dahl OM, Das S, Rollins RE, Eustis B, Schwartz A, Pertile P, Pavlopoulos I, Mayfield A, Marsh RH, Dibba Y, Kloepper D, Hall A, Huster K, Grady M, Spray K, Walton DA, Daboh F, Nally C, James S, Warren GS, Chang J, Drasher M, Lamin G, Bangura S, Miller AC, Michaelis AP, McBain R, Broadhurst MJ, Murray M, Richardson ET, Philip T, Gottlieb GL, Mukherjee JS, Farmer PE.

J Infect Dis. 2016 Oct 15;214(suppl 3):S153-S163. Epub 2016 Sep 28.

15.

Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures.

Leer-Salvesen S, Dybvik E, Dahl OE, Gjertsen JE, EngesæTer LB.

Acta Orthop. 2017 Feb;88(1):48-54. doi: 10.1080/17453674.2016.1235427. Epub 2016 Sep 23.

16.

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.

Lunde S, Kristoffersen EK, Sapkota D, Risa K, Dahl O, Bruland O, Mella O, Fluge Ø.

PLoS One. 2016 Aug 18;11(8):e0161226. doi: 10.1371/journal.pone.0161226. eCollection 2016.

17.

LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.

Stanisavljević L, Myklebust MP, Leh S, Dahl O.

Acta Oncol. 2016 Dec;55(12):1425-1433. Epub 2016 Jul 20.

PMID:
27435662
18.

Anaerobic co-digestion of acetate-rich with lignin-rich wastewater and the effect of hydrotalcite addition.

Rodriguez-Chiang L, Llorca J, Dahl O.

Bioresour Technol. 2016 Oct;218:84-91. doi: 10.1016/j.biortech.2016.06.074. Epub 2016 Jun 21.

PMID:
27347802
19.

Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.

Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K.

Cancer Med. 2016 Aug;5(8):1840-9. doi: 10.1002/cam4.766. Epub 2016 Jun 8.

20.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.

Mult Scler. 2017 Feb;23(2):213-219. doi: 10.1177/1352458516646863. Epub 2016 Jul 11.

Supplemental Content

Loading ...
Support Center